0001127602-22-014444.txt : 20220513 0001127602-22-014444.hdr.sgml : 20220513 20220513164122 ACCESSION NUMBER: 0001127602-22-014444 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220511 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REESE C RICHARD CENTRAL INDEX KEY: 0001032365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 22923471 MAIL ADDRESS: STREET 1: C/O IRON MOUNTAIN INC STREET 2: 745 ATLANTIC AVE 10TH FLR CITY: BOSTON STATE: MA ZIP: 02111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-11 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001032365 REESE C RICHARD 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Common Stock 2022-05-11 4 A 0 575 0 A 64053 D Common Stock 2022-05-11 4 A 0 382 0 A 64435 D Stock Options (Right to Buy) 222.31 2022-05-11 4 A 0 1582 222.31 A 2023-05-11 2032-05-11 Common Stock 1582 1582 D The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders. The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders. The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders. /s/ C. Richard Reese 2022-05-13